Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Effect of Rosa damascena on the Severity of Depression and Anxiety in Postmenopausal Women: A Randomized, Double-blind, Placebo-controlled Clinical Trial

مجله مراقبت مبتنی بر شواهد، دوره: 11، شماره: 1
Year: 1400
COI: JR_EBCJ-11-1_004
Language: EnglishView: 80
This Paper With 10 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 10 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:

Authors

Qamar Riazi - M.Sc. of Midwifery, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Masoumeh Simbar - Professor of Reproductive Health, Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Sedigheh Amir Ali AKbari - Assistant Professor of Health Sciences, Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Faraz Mojab - Professor of Pharmacognosy, Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Nezhat Shakeri۵ - ۵. Associate Professor of Biostatistics, Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract:

Background: Depression and anxiety as the most common psychological disorders reduce the quality of life in women during menopause. Aim: Given the potential therapeutic properties of Rosa damascena, the present study aimed to investigate the effect of Rosa damascena on the severity of depression and anxiety in postmenopausal women. Method: This clinical trial was conducted on ۱۱۰ postmenopausal women in Tehran, Iran, during ۲۰۲۰. The participants in the intervention group received ۵۰۰ mg dried Rosa damascena capsules, and the control group received placebo capsules three times a day (once every ۸ hours) for ۴۰ days. The data were collected using a demographic characteristics form, Beck's Depression Inventory, Spielberger's State-Trait Anxiety Inventory, and adverse effects questionnaire. Subsequently, the data were analyzed in SPSS software (version ۱۹) through the independent t-test, chi-square, Mann-Whitney, and repeated measures tests. Results: There was no difference in the mean score of depression before and ۲۰ days after the intervention in the intervention group; however, this difference was significant ۴۰ days after the intervention (p <۰.۰۵). The severity of anxiety differed significantly in the intervention group on days ۲۰ and ۴۰ post-intervention (p <۰.۰۰۱); however, these changes were not significant in the placebo group. The mean score of anxiety ۲۰ and ۴۰ days and depression ۴۰ days after the intervention showed a significant difference between the two groups (p <۰.۰۰۱). Implications for Practice: It seems that R. damascena has effects on postmenopausal depression and anxiety. Accordingly, menopausal women are recommended to use R. damascena as an efficient non-pharmacological intervention.  

Keywords:

Paper COI Code

This Paper COI Code is JR_EBCJ-11-1_004. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1254074/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Riazi, Qamar and Simbar, Masoumeh and Amir Ali AKbari, Sedigheh and Mojab, Faraz and Shakeri۵, Nezhat,1400,Effect of Rosa damascena on the Severity of Depression and Anxiety in Postmenopausal Women: A Randomized, Double-blind, Placebo-controlled Clinical Trial,https://civilica.com/doc/1254074

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Bahri N, Latifnejad Roudsari R, Azimi Hashemi M. Menopause research ...
  • Saei Ghare Naz M, Sayehmiri F, Kiani F, Ozgoli G. ...
  • Golshiri P, Akbari M, Abdollahzadeh MR. Age at natural menopause ...
  • Niazi A, Moradi M. Sexual satisfaction and function in postmenopausal ...
  • Gava G, Orsili I, Alvisi S, Mancini I, Seracchioli R, ...
  • Ciappolino V, Mazzocchi A, Enrico P, Syrén ML, Delvecchio G, ...
  • Bryant C, Kleinstäuber M, Judd F. Aspects of mental health ...
  • Gharraee B, Tajrishi KZ, Sheybani F, Tahmasbi N, Mirzaei M, ...
  • Zheng Y, Zhou Y, Hu J, Zhu J, Hua Q, ...
  • Freeman E. Depression in the menopause transition : risks in the ...
  • Jung SJ, Shin A, Kang D. Hormone-related factors and post-menopausal ...
  • Messina M, Gleason C. Evaluation of the potential antidepressant effects ...
  • Ziagham S, Sayhi M, Azimi N, Akbari M, Davari DN, ...
  • Bahri N, Afiat M, Aghamohamadian HR, Delshad Noughabi A, Bahri ...
  • Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, ...
  • Kornstein SG, Young EA, Harvey AT, Wisniewski SR, Barkin JL, ...
  • Ee C, Xue C, Chondros P, Myers SP, French SD, ...
  • Prague JK, Roberts RE, Comninos AN, Sophie C, Channa NJ, ...
  • Kazemian A, Parvin N, Raeisi Dehkordi Z, Rafieian-Kopaei M. The ...
  • Kargozar R, Azizi H, Salari R. A review of effective ...
  • Mohebitabar S, Shirazi M, Bioos S, Rahimi R, Malekshahi F, ...
  • Nayebi N, Khalili N, Kamalinejad M, Emtiazy M. A systematic ...
  • Mahboubi M. Rosa damascena as holy ancient herb with novel ...
  • Rakhshandah H, Shakeri MT, Ghasemzadeh MR. Comparative hypnotic effect of ...
  • Bikmoradi A, Harorani M, Roshanaei G, Moradkhani S, Falahinia GH. ...
  • Shewale PB, Patil RA, Hiray YA. Antidepressant-like activity of anthocyanidins ...
  • Nazıroğlu M, Kozlu S, Yorgancıgil E, Uğuz AC, Karakuş K. ...
  • Nyeem A, Alam M, Awal M, Mostafa M, Uddin S, ...
  • Esfandiary E, Abdolali Z, Omranifard V, Ghanadian M, Bagherian-Sararoud R, ...
  • Farnia V, Hojatitabar S, Shakeri J, Rezaei M, Yazdchi K, ...
  • Munro BH. Statistical methods for health care research. Philadelphia: Lippincott ...
  • Tadayon Najafabadi M, Shalikar Z, Adedi P, Bamshad Z. The ...
  • Beck A. An inventory for measuring depression. Arch Gen Psychol. ...
  • Hamidi R, Fekrizadeh Z, Azadbakht M, Garmarudi G, Taheri P, ...
  • Speilberger CD, Gorush RL, Lushene RE, Vagg PR, Jacobs GA. ...
  • Mahram B. The guideline for state and trait spielberger anxiety ...
  • Forouzanmehr S, Zendehdel T, Mirmohammadali M, Faghihzadeh S. Valerian effect ...
  • Kheirkhah M, Pour NSV, Nisani L, Haghani H. Comparing the ...
  • Hamdamian S, Nazarpour S, Simbar M, Hajian S, Mojab F, ...
  • Ankarali S, Beyazcicek E, Kilinc E, Beyazcicek O, Ozkan K, ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 5,410
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support